Matthew Goff Investment Advisor, LLC Organon & Co. Transaction History

Matthew Goff Investment Advisor, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $728 - $894	-23 Reduced 0.37%	6,227 $210,000
Q1 2022 Apr 19, 2022	BUY	$30.45 - $39.36 $190,312 - $246,000	6,250 New	6,250 $218,000
Q4 2021 Jan 18, 2022	SELL	$28.67 - $37.13 $188,046 - $243,535	-6,559 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$28.63 - $35.64 $2,233 - $2,779	-78 Reduced 1.18%	6,559 $215,000
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $188,822 - $252,206	6,637 New	6,637 $201,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Matthew Goff Investment Advisor, LLC, based on Form 13F filings with the SEC.

Stay updated on Matthew Goff Investment Advisor, LLC with notifications on news.